Patents by Inventor Adam Fivush

Adam Fivush has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purine derivatives as liver X receptor agonists
    Patent number: 7495004
    Abstract: The invention relates to methods for the treatment or prevention of an LXR mediated disease or condition, including cardiovascular disease and atherosclerosis, novel compounds of formula (I) for use in such methods and pharmaceutical compositions comprising compounds for use in such methods.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: February 24, 2009
    Assignee: Glaxo Group Limited
    Inventors: Sharon Davis Boggs, Jon Loren Collins, Adam Fivush, Eugene Lee Stewart, Timothy Mark Willson
  • Purine derivatives as liver x receptor agonists
    Publication number: 20060094733
    Abstract: The invention relates to methods for the treatment or prevention of an LXR mediated disease or condition, including cardiovascular disease and atherosclerosis, novel compounds for use in such methods and pharmaceutical compositions comprising compounds for use in such methods.
    Type: Application
    Filed: May 20, 2003
    Publication date: May 4, 2006
    Applicant: Glaxo Group Limited
    Inventors: Sharon Boggs, Jon Loren Collins, Adam Fivush, Eugene Stewart, Timothy Willson
  • Substituted aminopropoxyaryl derivatives useful as agonists for LXR
    Publication number: 20050282908
    Abstract: The invention relates to a compound of formula (I), wherein all variables are as defined herein, and pharmaceutically acceptable salts or solvates thereof. The compounds of formula (I) are useful as LXR agonists.
    Type: Application
    Filed: June 16, 2005
    Publication date: December 22, 2005
    Inventors: Jon Collins, Adam Fivush, Patrick Maloney, Eugene Stewart, Timothy Willson